Dienogest

Basic Information

Item Value
DrugBank ID DB09123
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 100

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 amenorrhea (disease) KG + DL
2 primary ovarian failure KG + DL
3 breast fibrocystic disease KG + DL
4 isolated growth hormone deficiency KG + DL
5 symptomatic form of fragile X syndrome in female carrier KG + DL
6 blepharophimosis-epicanthus inversus-ptosis KG + DL
7 hypogonadotropic hypogonadism with or without anosmia KG + DL
8 partial trisomy/tetrasomy of the short arm of chromosome 5 KG + DL
9 blepharophimosis-epicanthus inversus-ptosis due to 3q23 rearrangement syndrome KG + DL
10 partial trisomy/tetrasomy of the short arm of chromosome 18 KG + DL
11 partial trisomy/tetrasomy of the short arm of chromosome 12 KG + DL
12 anovulation KG + DL
13 ovarian remnant syndrome KG + DL
14 luteoma of pregnancy KG + DL
15 ovarian dysfunction KG + DL
16 partial autosomal trisomy/tetrasomy KG + DL
17 stapes ankylosis with broad thumbs and toes KG + DL
18 ovarian ectopic pregnancy KG + DL
19 benign mammary dysplasia KG + DL
20 telecanthus KG + DL
21 midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis KG + DL
22 ovarian hyperstimulation syndrome KG + DL
23 Leydig cell hypoplasia due to LH resistance KG + DL
24 46,XY disorder of sex development due to impaired androgen production KG + DL
25 blunt duct adenosis of breast KG + DL
26 apocrine adenosis of breast KG + DL
27 acne (disease) KG + DL
28 pituitary hormone defiency from vascular origin KG + DL
29 non-acquired combined pituitary hormone deficiencies without extra-pituitary malformations KG + DL
30 breast abscess KG + DL
31 fat necrosis of breast KG + DL
32 female infertility KG + DL
33 hypogonadotropic hypogonadism-frontoparietal alopecia syndrome KG + DL
34 lactation disease KG + DL
35 breast adenosis KG + DL
36 premature menopause KG + DL
37 polysomy of X chromosome KG + DL
38 46,XY disorder of sex development due to testicular steroidogenesis defect KG + DL
39 hypogonadism KG + DL
40 short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia KG + DL
41 transverse vaginal septum KG + DL
42 longitudinal vaginal septum KG + DL
43 pregnancy associated osteoporosis KG + DL
44 Worth syndrome KG + DL
45 menstrual cycle-dependent periodic fever KG + DL
46 hypogonadotropic hypogonadism KG + DL
47 epilepsia partialis continua KG + DL
48 extratemporal epilepsy KG + DL
49 post-traumatic epilepsy KG + DL
50 structural epilepsy KG + DL

(Showing top 50 of 100 predictions)

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). 本報告僅供研究參考,不構成醫療建議。

This site uses Just the Docs, a documentation theme for Jekyll.